ANKURDRUGS

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 10, 2012, has taken the following decisions : (1) Letter received from the Nominee Director Mr. A. K. Khadke (Representative of Central Bank of India) requiring the Company to indemnify with costs, expenses and interests for any damage caused to him on account of his being on the board of the Company has been taken on record.

Ankur Drugs And Pharma Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled on September 29, 2012 has been cancelled due to unavoidable circumstances.

Ankur Drugs And Pharma Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled on September 04, 2012 has been cancelled till further notice in this respect.

Ankur Drugs And Pharma Limited has informed the Exchange regarding the outcome of Board Meeting of the Company held on May 14, 2012.

Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of the Outcome of the Board Meeting of the Company held on February 01, 2012.

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors of the Company held on November 14, 2010 has passed the resolutions for the following: 1) The Board has decided to seek the consent of the members through a process of postal ballot under Section 192A of the Companies Act, 1956 for the following: (i) To create charge/ hypothecate / mortgage property of the company in pursuance of Section 293(1) (a) of the Companies Act,1956. (ii) To obtain ratification from the members for the allotment of shares made on May 12, 2009, pursuant to conversion of warrants.(iii) A

Ankur Drugs And Pharma Limited has informed the Exchange that the company has passed the following resolutions at the meeting of its Board of Directors held on April 01, 2010: The board decided to invest in the entire paid up share capital of TVC Life Sciences Limited in order to make it its wholly owned subsidiary. Since this transaction is within the limits of section 372A no shareholders permission would be required. Currently TVC Sky Shop Limited hold 99.94% shares in share capital of TVC Life Sciences Limited.

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors in their meeting held on October 28, 2009 has passed the resolution for the following: Constitution of a Finance Committee for arrangement with banks and financial institutions for borrowing of money.

Ankur Drugs And Pharma Limited has informed the Exchange that the proposal to create and/or charge and/or hypothecate all or any of the moveable and immovable properties, assets of the Company in pursuance of Section 293(1)(a) of the Companies Act, 1956 which was placed for consideration of the Board of Directors of the Company at its meeting held on June 15, 2009 was approved thereat. The Board has also approved seeking the consent of the Members to the said proposal through the process of Postal Ballot under Section 192A of the Companies Act, 1956. The Board has also approved the Calendar of

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors in its meeting held on May 12, 2009 resolved: (1) To allot 4,00,000 fully paid equity shares of Rs. 10 each to Mr. Purnandu Jain pursuant to conversion of its 4,00,000 share warrants (each warrant convertible into 1 equity share of Rs. 10 /- each) held by Mr. Purnandu Jain at an agreed price of Rs.175/- per share warrant, as per the terms of issue of share warrants on a preferential basis. (2) To forfeit the amount received on remaining 17,24,400 share warrants on account of non-exercise of the right of conver

Ankur Drugs And Pharma Limited has informed the Exchange that the company has allotted Equity Share Warrants & Equity shares in the Meeting of Board of Directors held on September 05, 2007. (1)The Company has allotted 21,24,400 Equity Share Warrants to Promoters, Friends, Relatives, Employees & business associates. (2) The Company has also allotted 20,43,000 Equity Shares of the Company on Preferential allotment basis. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate An